Results 81 to 90 of about 12,537 (253)
“What Medical Management Should Be First Line for Bladder Storage Symptoms in NLUTD”—Pro Botox
Neurourology and Urodynamics, EarlyView.ABSTRACT Objectives Neurogenic lower urinary tract dysfunction (NLUTD) severely impairs patient quality of life (QoL). While oral medications are often first‐line treatments, their high failure rates and side effects limit their effectiveness. Thus, we argue for the use of intravesical botulinum toxin A (BoNT‐A) injections as a first‐line alternative ...
Vada Furlan +2 more
wiley +1 more source
Comparison of botulinum toxins for treatment of movement disorders: real-world utilization and cost analysis in a national Medicare population. [PDF]
J Manag Care Spec Pharm, 2021 Kazerooni R, Watanabe JH.
europepmc +1 more source
Adverse Effects Linked to Counterfeit or Mishandled Botulinum Toxin Injections [PDF]
Distributed via the CDC Health Alert NetworkApril 23 2024, 11:00 AM ETCDCHAN-00507The Centers for Disease Control and Prevention (CDC) is issuing this Health Alert Network (HAN) Health Advisory to alert clinicians about risks of counterfeit or mishandled
core
Botulinum Neurotoxins: Still a Privilege of Clostridia?
, 2018 Comment on : Identification of a Botulinum Neurotoxin-like Toxin in a Commensal Strain of Enterococcus faecium. [Cell Host Microbe. 2018]International audienceBotulinum neurotoxins (BoNTs) are potent bacterial toxins mostly produced by genetically ...
Michel R. Popoff, Popoff, Michel, R.
core +1 more source
Expanding the Phenotype of PARK‐PRKN to Spastic Paraplegia: A Report of Two Cases
Movement Disorders Clinical Practice, EarlyView.
Nicolas Geoffre +5 more
wiley +1 more source
Neurourology and Urodynamics, EarlyView.ABSTRACT Background & Aims Neurogenic lower urinary tract dysfunction (NLUTD) can produce bothersome urinary symptoms, impact quality of life, and in some cases, lead to deterioration of upper urinary tract function. Intradetrusor injection of onabotulinumtoxin‐A (BoNT‐A) is approved for NLUTD in patients who have an inadequate response to or ...
Shirley L. Wang +2 more
wiley +1 more source
Botulinum toxins for dystonia [PDF]
, 2017 RESUMEN La toxina botulínica es actualmente en tratamiento de elección para las distonía focales y algunos segmentos del cuerpo en casos de distonía generalizada.
Moreno López, Claudia Lucía +2 more
core
Neurourology and Urodynamics, EarlyView.ABSTRACT Objective To synthesize the evidence on the efficacy and safety of mirabegron and intradetrusor onabotulinumtoxinA (BoNT‐A) as separate interventions for overactive bladder (OAB) in Parkinson's disease (PD). Methods A systematic review and meta‐analysis with parallel synthesis of two distinct interventions was conducted of randomized and ...
Hussain Arshad +4 more
wiley +1 more source
, 2010 Paul S Yamauchi1,21Dermatology Institute and Skin Care Center, Santa Monica, CA, 2Division of Dermatology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USAAbstract: Various noninvasive to minimally invasive techniques can be used for the ...
Paul S Yamauchi
core
Endoscopic small bowel therapies for type 2 diabetes
Nutrition in Clinical Practice, EarlyView.Abstract Type 2 diabetes is a global epidemic despite current medical treatments. Many patients are not responsive to medications, and patients with obesity are hesitant about bariatric surgery. Studies investigating the metabolic effects of Roux‐en‐Y gastric bypass have increasingly demonstrated that the duodenum plays a key role in the ...
Roma Patel +4 more
wiley +1 more source